Preventing Diabetes in Latino Youth
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT02615353 |
Recruitment Status :
Completed
First Posted : November 26, 2015
Last Update Posted : October 14, 2022
|
Sponsor:
Arizona State University
Collaborators:
Phoenix Children's Hospital
St. Vincent de Paul Medical and Dental Clinic
Valley of the Sun YMCA, Arizona
University of Washington
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Information provided by (Responsible Party):
Arizona State University
Tracking Information | |||
---|---|---|---|
First Submitted Date ICMJE | November 4, 2015 | ||
First Posted Date ICMJE | November 26, 2015 | ||
Last Update Posted Date | October 14, 2022 | ||
Actual Study Start Date ICMJE | May 13, 2016 | ||
Actual Primary Completion Date | March 15, 2020 (Final data collection date for primary outcome measure) | ||
Current Primary Outcome Measures ICMJE |
|
||
Original Primary Outcome Measures ICMJE |
Improvements in Glucose Tolerance [ Time Frame: 12-months ] Reductions in 2-hour glucose following an oral glucose tolerance test
|
||
Change History | |||
Current Secondary Outcome Measures ICMJE |
|
||
Original Secondary Outcome Measures ICMJE |
|
||
Current Other Pre-specified Outcome Measures | Not Provided | ||
Original Other Pre-specified Outcome Measures | Not Provided | ||
Descriptive Information | |||
Brief Title ICMJE | Preventing Diabetes in Latino Youth | ||
Official Title ICMJE | Preventing Diabetes in Latino Youth | ||
Brief Summary | Obesity and type 2 diabetes are critical public health issues in youth. This study will test the effects and estimate the cost-effectiveness of a culturally-grounded community-based lifestyle intervention on type 2 diabetes risk among obese Latino adolescents with prediabetes. | ||
Detailed Description | Obesity and related health disparities represent some of the most significant public health challenges facing society. In particular, obese Latino adolescents are disproportionately impacted by insulin resistance and type 2 diabetes. Prediabetes is an intermediate stage in the pathogenesis of type 2 diabetes and represents a critical opportunity for intervention. The Diabetes Prevention Program established that lifestyle intervention can prevent or delay type 2 diabetes in adults with prediabetes. To date, no diabetes prevention studies have been conducted in obese Latino youth with prediabetes, a highly vulnerable and underserved group. Therefore, investigators propose a randomized-controlled trial to test the short-term (6-month) and long-term (12-month) efficacy of a culturally-grounded, lifestyle intervention, as compared to usual care, for improving glucose tolerance and reducing diabetes risk in 120 obese Latino adolescents with prediabetes. Investigators will further test intervention effects on changes in quality of life, explore the potential mediating effects of changes in total, regional, and organ fat on improving glucose tolerance and increasing insulin sensitivity, and estimate the initial incremental cost-effectiveness of the intervention as compared with usual care for improving glucose tolerance. The overall approach is framed within a multilevel Ecodevelopmental model that leverages community, family, peer, and individual factors during the critical transition period of adolescence when changes in health behaviors and health outcomes are linked to future health trajectories. The intervention is guided by Social Cognitive Theory and employs key behavioral modification strategies to enhance self-efficacy and foster social support for making and sustaining healthy behavior changes. The proposal builds upon extant collaborations of a transdisciplinary team of investigators working in concert with local community agencies to address critical gaps in how diabetes prevention interventions for obese Latino youth are developed, implemented and evaluated. This innovative approach is an essential step in the development of scalable, cost-effective, solution-oriented programs to prevent type 2 diabetes in this and other populations of high-risk youth. | ||
Study Type ICMJE | Interventional | ||
Study Phase ICMJE | Not Applicable | ||
Study Design ICMJE | Allocation: Randomized Intervention Model: Parallel Assignment Masking: None (Open Label) Primary Purpose: Prevention |
||
Condition ICMJE |
|
||
Intervention ICMJE |
|
||
Study Arms ICMJE |
|
||
Publications * |
|
||
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline. |
|||
Recruitment Information | |||
Recruitment Status ICMJE | Completed | ||
Actual Enrollment ICMJE |
117 | ||
Original Estimated Enrollment ICMJE |
120 | ||
Actual Study Completion Date ICMJE | March 15, 2020 | ||
Actual Primary Completion Date | March 15, 2020 (Final data collection date for primary outcome measure) | ||
Eligibility Criteria ICMJE | Inclusion Criteria:
Exclusion Criteria:
|
||
Sex/Gender ICMJE |
|
||
Ages ICMJE | 12 Years to 16 Years (Child) | ||
Accepts Healthy Volunteers ICMJE | No | ||
Contacts ICMJE | Contact information is only displayed when the study is recruiting subjects | ||
Listed Location Countries ICMJE | United States | ||
Removed Location Countries | |||
Administrative Information | |||
NCT Number ICMJE | NCT02615353 | ||
Other Study ID Numbers ICMJE | 1R01DK107579-01( U.S. NIH Grant/Contract ) 3R01DK107579-03S1 ( U.S. NIH Grant/Contract ) |
||
Has Data Monitoring Committee | Yes | ||
U.S. FDA-regulated Product | Not Provided | ||
IPD Sharing Statement ICMJE |
|
||
Current Responsible Party | Arizona State University | ||
Original Responsible Party | Same as current | ||
Current Study Sponsor ICMJE | Arizona State University | ||
Original Study Sponsor ICMJE | Same as current | ||
Collaborators ICMJE |
|
||
Investigators ICMJE | Not Provided | ||
PRS Account | Arizona State University | ||
Verification Date | October 2022 | ||
ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP |